4DPharma PLC   Report issue

For profit Phase 1 Phase 2
Founded: Aberdeen United Kingdom (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2018
NCT03637803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

4D pharma plc | 4DPharma PLC